CSP
1 min read
13

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 30.12.2024

December 30, 2024
0

Reading Time: < 1 minute Stock Exchange Release 30.12.2024 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 30.12.2024   Date 30.12.2024   Exchange transaction Buy   Share class FSKRS   Amount  819   Average price/share 14.6022 EUR Highest price/share 14.6600 EUR Lowest price/share

Continue Reading
CSP
15 min read
10

Eevia Health Plc plans to arrange a rights issue having maximum amount of approximately SEK 12.1 million to finance its strategic reorientation and turnaround plan

December 30, 2024
0

Reading Time: 11 minutes The Board of Directors of Eevia Health Plc (“Eevia” or the “Company”) has today decided on its intention to execute a rights issue of shares, with preferential rights for the Company’s existing shareholders, having maximum amount of approximately SEK 12.1 before deduction

Continue Reading
CSP
2 min read
7

Buy-back of shares in MTG during week 52, 2024

December 30, 2024
0

Reading Time: 2 minutes During the period between 23 December and 27 December 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 34,649 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.

Continue Reading
CSP
2 min read
8

CryptoCasinoRank Unveils Key Insights into the Best Crypto Casinos of 2025

December 30, 2024
0

Reading Time: 2 minutes Stockholm, Sweden, December 2024 – CryptoCasinoRank, a trusted authority in cryptocurrency gambling analysis, has revealed the defining characteristics of the best crypto casinos poised to lead the industry in 2025. With digital currencies continuing to transform the iGaming sector, these platforms are

Continue Reading
CSP
1 min read
10

Calligo publishes its monthly management accounts for November 2024

December 30, 2024
0

Reading Time: < 1 minute The Company has today, the 30th of December 2024, published its November 2024 unaudited consolidated monthly management accounts for the Calligo group, which can be viewed on the Company’s website. Brendan Walsh, Company Secretary & General Counsel

Continue Reading
Pristyn Care Reports Robust Financial Growth in FY 23-24, Operating Revenue Jumps 33 percent, Aims for Profitability by FY 26
NV
2 min read
36

Pristyn Care Reports Robust Financial Growth in FY 23-24, Operating Revenue Jumps 33 percent, Aims for Profitability by FY 26

December 30, 2024
0

Reading Time: 2 minutes Gurugram, Haryana, India Pristyn Care, India’s leading healthcare provider specializing in secondary care surgeries, has filed its audited financials for the year 2023-24. The results highlight strong revenue growth and a significant reduction in operational costs across key segments. The company reported consolidated

Continue Reading
CSP
2 min read
39

Buybacks of shares by Scandic during week 52, 2024

December 30, 2024
0

Reading Time: 2 minutes Between 23 December 2024 and 27 December 2024, Scandic Hotels Group AB (publ) (LEI: 529900JY9ZBGUXGRKQ86) has repurchased in total 142,060 own shares (ISIN: SE0007640156) as part of the share buyback program initiated by the Board of Directors. The buybacks form part

Continue Reading
CSP
3 min read
10

Dataloy Caps Off 2024 with Record Growth and Q4 Innovations Driving Maritime Excellence

December 30, 2024
0

Reading Time: 2 minutes Closing 2024 with close to 25% revenue growth, including a strong fourth quarter, Dataloy Systems continues to strengthen its position in maritime digitalisation. Bergen, Norway – 30 December 2024 – Dataloy Systems, a global leader in voyage management solutions, concludes 2024 on

Continue Reading
Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group
CSP
3 min read
11

Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group

December 30, 2024
0

Reading Time: 3 minutes Since 2021, Scandinavian ChemoTech has operated two distinct business units – Human Care and Animal Care. While Human Care was the group’s initial focus, the Board of Directors has made key decisions to support the independence and growth of the two separate

Continue Reading
Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals, Inc.
CSP
11 min read
10

Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals, Inc.

December 30, 2024
0

Reading Time: 7 minutes Stockholm, Sweden and Radnor, Pa. – December 30, 2024 – Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq:  MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today

Continue Reading